Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1

被引:39
|
作者
Hashiramoto, A.
Mizukami, H.
Yamashita, T.
机构
[1] Kobe Univ, Dept Rheumatol, FHS Sch Med, Kobe, Hyogo 6540142, Japan
[2] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
[3] Hirosaki Univ, Sch Med, Dept Pathol, Hirosaki, Aomori 036, Japan
[4] Univ Tokyo, Inst Med Sci, Dept Cell Proc, Tokyo, Japan
基金
美国国家卫生研究院;
关键词
GM3; MAPK; cell cycle; c-Fos; AP-1;
D O I
10.1038/sj.onc.1209416
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gangliosides have been proposed as modulators of transmembrane signaling. Recently, GM3, a glycosphingolipid containing monosaialic acids, is thought to be one of the key molecules of signal transduction in mammalian cells. In this study, we used mouse embryonic fibroblast cell lines (MEFs) established from sialyltransferase-I knockout mice (GM3 synthase KO mice) to evaluate the regulation of mitogenic signals by gangliosides. Cell proliferation assay revealed a higher growth potential of GM3 KO MEFs. Immunoblots showed upregulation of Ras/Raf/MEK/ERK pathway in GM3 KO MEFs, and these signals resulted in enhanced translocation of ERK into the nuclei. Further, both exogenous and endogenous add-back of GM3 decreased the activities of MAPK in GM3 KO MEFs. In addition, GM3 KO MEFs formed foci in high-density culture condition, and analyses of cell cycle modulators revealed the resistance of GM3 KO MEFs for entering cell cycle arrest. Finally, sustained expressions of c-Fos in GM3 KO MEFs were shown to correlate with DNA-binding activity between c-Fos and AP-1. These results demonstrate that the deletion of sialyltransferase-I changes the character of MEFs to a highly activated state of the MAPK pathway, indicating the critical role of GM3 as a regulator of membrane-transmitted signals.
引用
收藏
页码:3948 / 3955
页数:8
相关论文
共 50 条
  • [1] Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1
    A Hashiramoto
    H Mizukami
    T Yamashita
    Oncogene, 2006, 25 : 3948 - 3955
  • [2] Role of c-Fos/AP-1 in the progression to squamous cell carcinomas
    Briso, E. M.
    Bakiri, L.
    Guinea-Viniegra, J.
    Wagner, E. F.
    EJC SUPPLEMENTS, 2010, 8 (05): : 89 - 90
  • [3] Pathogenesis of rheumatoid arthritis and c-Fos/AP-1
    Shiozawa, Shunichi
    Tsumiyama, Ken
    CELL CYCLE, 2009, 8 (10) : 1539 - 1543
  • [4] THE C-FOS PROTEIN INTERACTS WITH C-JUN/AP-1 TO STIMULATE TRANSCRIPTION OF AP-1 RESPONSIVE GENES
    CHIU, R
    BOYLE, WJ
    MEEK, J
    SMEAL, T
    HUNTER, T
    KARIN, M
    CELL, 1988, 54 (04) : 541 - 552
  • [5] A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C
    Ivorra', C
    Kubicek, M
    González, JM
    Sanz-González, SM
    Alvarez-Barrientos, A
    O'Connor, LE
    Burke, B
    Andrés, V
    GENES & DEVELOPMENT, 2006, 20 (03) : 307 - 320
  • [6] Intracellular pathways linking hypoxia to activation of c-fos and AP-1
    Premkumar, DR
    Adhikary, G
    Overholt, JL
    Simonson, MS
    Cherniack, NS
    Prabhakar, NR
    OXYGEN SENSING: MOLECULE TO MAN, 2000, 475 : 101 - 109
  • [7] Studies on the contribution of c-fos/AP-1 to arthritic joint destruction
    Shiozawa, S
    Shimizu, K
    Tanaka, K
    Hino, K
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06): : 1210 - 1216
  • [8] A ROLE FOR C-FOS/AP-1 IN CHOLANGIOPATHIES AND POLYCYSTIC LIVER DISEASE?
    Bakiri, L.
    Hasenfuss, S. C.
    Wagner, E. F.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S554 - S554
  • [9] Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
    Weekes, D.
    Kashima, T. G.
    Zandueta, C.
    Perurena, N.
    Thomas, D. P.
    Sunters, A.
    Vuillier, C.
    Bozec, A.
    El-Emir, E.
    Miletich, I.
    Patino-Garcia, A.
    Lecanda, F.
    Grigoriadis, A. E.
    ONCOGENE, 2016, 35 (22) : 2852 - 2861
  • [10] Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
    D Weekes
    T G Kashima
    C Zandueta
    N Perurena
    D P Thomas
    A Sunters
    C Vuillier
    A Bozec
    E El-Emir
    I Miletich
    A Patiño-Garcia
    F Lecanda
    A E Grigoriadis
    Oncogene, 2016, 35 : 2852 - 2861